← Open Payments lookup

TENZIN DECHEN: Open Payments

NPI 1043750318 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$619 in 5 payments from 5 companies in 2025. Trend: 2023 $18 · 2024 $604 · 2025 $619

Food & beverage: $619
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$140
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
ABBVIE INC.1$125
Teva Pharmaceuticals USA, Inc.1$116
Otsuka America Pharmaceutical, Inc.1$113

Products named: INGREZZA, CAPLYTA, VRAYLAR, AUSTEDO XR, REXULTI.

Industry payments across PA — which companies pay providers there.